Novartis and BenevolentAI sign AI oncology deal

Swiss pharmaceutical company Novartis has united with BenevolentAI to aid in the discovery and development of new treatments. BenevolentAI, a UK-headquartered artificial intelligence (AI) company, announced the collaboration agreement on Friday, September 6. Novartis’ precision medicine team (which sits within the company’s global drug development unit) […]

Leave a Reply